Members

Leonor Arenillas Rocha (Researcher)

Luis Carlos Barranco Sanz (Researcher)

Gonzalo Blanco Ares (PhD Student)

Sergi Clavé Safont (Technician)

Lluís Colomo Saperas (Researcher)

Beatriz Costán Medina (Technician)

Ana Ferrer del Álamo (Researcher)

Fernando Gallardo Hernández (Researcher)

Belén Lloveras Rubio (Researcher)

M. Carme Melero Vilella (Technician)

Carme Pedro Olivé (Researcher)

Anna Maria Puiggros Metje (Researcher)

Clea Renard Marine (Technician)

Maria del Mar Rodríguez Rivera (Technician)

Marta Salido Galeote (Researcher)

 

• Main Publications
• Ongoing Research Projects
• Participation in Research Networks

• Group’s Recognitions
• Clinical Trials Signed in 2016

Main Publications

• Arenillas L, Calvo X, Luño E, Senent L, Alonso E, Ramos F, Ardanaz MT, Pedro C, Tormo M, Marco V, Montoro J, Diez-Campelo M, Brunet S, Arrizabalaga B, Xicoy B, Andreu R, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L. Considering Bone Marrow Blasts From Nonerythroid Cellularity Improves the Prognostic Evaluation of Myelodysplastic Syndromes. J Clin Oncol 2016; 34(27): 3284-3292. IF 20.982. Q1.

• Baliakas P, Puiggros A, Xochelli A, Sutton LA, Nguyen-Khac F, Gardiner A, Plevova K, Minga E, Hadzidimitriou A, Walewska R, McCarthy H, Ortega M, Collado R, González T, Granada I, Luño E, Kotašková J, Moysiadis T, Davis Z, Stavroyianni N, Anagnostopoulos A, Strefford JC, Pospisilova S, Davi F, Athanasiadou A, Rosenquist R, Oscier D, Espinet B, Stamatopoulos K. Additional trisomies amongst patients with chronic lymphocytic leukemia carrying trisomy 12: the accompanying chromosome makes a difference. Haematologica 2016; 101(7): e299-e302. IF 6.671. Q1.

• Blanco G, Puiggros A, Baliakas P, Athanasiadou A, García-Malo M, Collado R, Xochelli A, Rodríguez-Rivera M, Ortega M, Calasanz MJ, Luño E, Vargas M, Grau J, Martínez-Laperche C, Valiente A, Cervera J, Anagnostopoulos A, Gimeno E, Abella E, Stalika E, Hernández-Rivas JM, Ortuño FJ, Robles D, Ferrer A, Ivars D, González M, Bosch F, Abrisqueta P, Stamatopoulos K, Espinet B. Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations. Oncotarget 2016; 7(49): 80916-80924. IF 5.008. Q1.

• Calvo X, Arenillas L, Luño E, Senent L, Arnan M, Ramos F, Ardanaz MT, Pedro C, Tormo M, Montoro J, Diez-Campelo M, Arrizabalaga B, Xicoy B, Bonanad S, Jerez A, Nomdedeu B, Ferrer A, Sanz GF, Florensa L, and on behalf of Grupo Español de Síndromes Mielodisplásicos (GESMD). Erythroleukemia shares biological features and outcome with myelodysplastic syndromes with excess blasts: a rationale for its inclusion into future classifications of myelodysplastic syndromes. Modern Pathol 2016; 29(12): 1541-1551. IF 5.485. Q1.

• Hastings RJ, Bown N, Tibiletti MG, Debiec-Rychter M, Vanni R, Espinet B, van Roy N, Roberts P, van den Berg-de-Ruiter E, Bernheim A, Schoumans J, Chatters S, Zemanova Z, Stevens-Kroef M, Simons A, Heim S, Salido M, Ylstra B, Betts DR. Guidelines for cytogenetic investigations in tumours. Eur J Hum Genet 2016; 24(1): 6-13. IF 4.58. Q1.

• Prasad A, Rabionet R, Espinet B, Zapata L, Puiggros A, Melero C, Puig A, Sarria-Trujillo Y, Ossowski S, García-Muret MP, Estrach T, Servitje O, López-Lerma I, Gallardo F, Pujol RM, Estivill X. Identification of gene mutations and fusion genes in patients with Sézary Syndrome. J Invest Dermatol 2016; 136(7): 1490-1499. IF 6.915. Q1.

• Rovira J, Karube K, Valera A, Colomer D, Enjuanes A, Colomo L, Martínez-Trillos A, Giné E, Dlouhy I, Magnano L, Delgado J, Martínez A, Villamor N, Campo E, López-Guillermo A. MYD88 L265P mutations, but no other variants, identify a subpopulation of DLBCL patients of activated B-cell origin, extranodal involvement and poor outcome. Clin Cancer Res 2016; 22(11): 2755-2764. IF 8.738. Q1.

• Valera A, Epistolio S, Colomo L, Riva A, Balagué O, Dlouhy I, Tzankov A, Bühler M, Haralambieva E, Campo E, Soldini D, Mazzucchelli L, Martín V. Definition of MYC genetic heteroclonality in diffuse large B-cell lymphoma with 8q24 rearrangement and its impact on protein expression. Modern Pathol 2016; 29(8): 844-853. IF 5.485. Q1.